{"id":"https://openalex.org/W38472955","doi":null,"title":"Pharmacokinetics of oral antifungals and their clinical implications.","display_name":"Pharmacokinetics of oral antifungals and their clinical implications.","alternate_titles":[],"publication_year":1990,"publication_date":"1990-09-01","ids":{"openalex":"https://openalex.org/W38472955","mag":"38472955","pmid":"https://pubmed.ncbi.nlm.nih.gov/1965419"},"language":"en","primary_location":{"id":"pmid:1965419","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1965419","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of clinical practice. Supplement","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W38472955"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113762920","display_name":"J. Heykants","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"J Heykants","raw_affiliation_strings":["Department of Pharmacokinetics, Janssen Research Foundation, Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacokinetics, Janssen Research Foundation, Beerse, Belgium","institution_ids":["https://openalex.org/I137982388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109551188","display_name":"A. Van Peer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A Van Peer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073449834","display_name":"Karel Lavrijsen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K Lavrijsen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002960789","display_name":"W. Meuldermans","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W Meuldermans","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043194251","display_name":"R. Woestenborghs","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R Woestenborghs","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5110268418","display_name":"Geert F. M. J. Cauwenbergh","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G Cauwenbergh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.3521,"has_fulltext":false,"cited_by_count":31,"citation_normalized_percentile":{"value":0.60893785,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":93},"biblio":{"volume":"71","issue":null,"first_page":"50","last_page":"56"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.9868000149726868,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.9868000149726868,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.005900000222027302,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11037","display_name":"Fungal Infections and Studies","score":0.002400000113993883,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/itraconazole","display_name":"itraconazole","score":0.9750000238418579},{"id":"https://openalex.org/keywords/fluconazole","display_name":"fluconazole","score":0.9990000128746033},{"id":"https://openalex.org/keywords/oral-antifungal-agents","display_name":"oral antifungal agents","score":0.8640000224113464},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8989999890327454},{"id":"https://openalex.org/keywords/triazole-antifungals","display_name":"triazole antifungals","score":0.8610000014305115},{"id":"https://openalex.org/keywords/lipophilicity","display_name":"lipophilicity","score":0.8029999732971191},{"id":"https://openalex.org/keywords/tissue-distribution","display_name":"tissue distribution","score":0.8029999732971191},{"id":"https://openalex.org/keywords/drug-metabolism","display_name":"drug metabolism","score":0.5569999814033508},{"id":"https://openalex.org/keywords/cytochrome-p450-interactions","display_name":"cytochrome P450 interactions","score":0.8420000076293945},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.7889999747276306},{"id":"https://openalex.org/keywords/mycotic-infections","display_name":"mycotic infections","score":0.7960000038146973},{"id":"https://openalex.org/keywords/oral-absorption","display_name":"oral absorption","score":0.41200000047683716}],"concepts":[{"id":"https://openalex.org/C2777071850","wikidata":"https://www.wikidata.org/wiki/Q411229","display_name":"Itraconazole","level":3,"score":0.9530110359191895},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8966701030731201},{"id":"https://openalex.org/C2780651595","wikidata":"https://www.wikidata.org/wiki/Q411478","display_name":"Fluconazole","level":3,"score":0.8544652462005615},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.7202218770980835},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5642998814582825},{"id":"https://openalex.org/C110121322","wikidata":"https://www.wikidata.org/wiki/Q865811","display_name":"Distribution (mathematics)","level":2,"score":0.5575006604194641},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.4447310268878937},{"id":"https://openalex.org/C2779548794","wikidata":"https://www.wikidata.org/wiki/Q578726","display_name":"Antifungal","level":2,"score":0.23609527945518494},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.06614294648170471},{"id":"https://openalex.org/C134306372","wikidata":"https://www.wikidata.org/wiki/Q7754","display_name":"Mathematical analysis","level":1,"score":0.0},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000042","descriptor_name":"Absorption","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007654","descriptor_name":"Ketoconazole","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D007654","descriptor_name":"Ketoconazole","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D014018","descriptor_name":"Tissue Distribution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015725","descriptor_name":"Fluconazole","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D017964","descriptor_name":"Itraconazole","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:1965419","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1965419","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of clinical practice. Supplement","raw_type":"Journal Article"},{"id":"mag:38472955","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1965419","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2056863521","https://openalex.org/W2105749407","https://openalex.org/W150600898","https://openalex.org/W2016071165","https://openalex.org/W2370040653","https://openalex.org/W2043497010","https://openalex.org/W2947038","https://openalex.org/W2021321721","https://openalex.org/W2043527252","https://openalex.org/W1916615072"],"abstract_inverted_index":{"Orally":[0],"active":[1,91,108],"antifungals":[2],"have":[3,87],"different":[4],"physicochemical":[5],"and":[6,29,77,122,173,183,226],"pharmacokinetic":[7,218],"properties.":[8],"Itraconazole":[9],"is":[10,156],"a":[11,22,53,68,80,119],"broad-spectrum":[12],"triazole":[13],"antifungal":[14],"with":[15,52,59,146,152,163,204,213,232],"pronounced":[16],"lipophilicity.":[17],"This":[18],"property":[19],"determines":[20],"to":[21,189,222],"large":[23,81],"extent":[24],"the":[25,33,115,127,131,209,223],"pharmacokinetics":[26,39],"of":[27,40,73,83,93,130,171,186,211,228],"itraconazole":[28,41,145,200,229],"differentiates":[30],"it":[31],"from":[32],"hydrophilic":[34],"bistriazole":[35],"antifungal,":[36],"fluconazole.":[37,160],"The":[38],"in":[42,66,99,104,114,126,168,177,192,230],"man":[43,193],"are":[44,95,179],"characterised":[45],"by":[46],"good":[47],"oral":[48],"absorption":[49],"(when":[50],"taken":[51],"meal),":[54],"an":[55],"extensive":[56],"tissue":[57,60,154],"distribution":[58,140],"concentrations":[61,150,185],"many":[62],"times":[63],"higher":[64],"than":[65,103],"plasma,":[67],"relatively":[69,147],"long":[70],"elimination":[71],"half-life":[72],"about":[74],"one":[75],"day,":[76],"biotransformation":[78],"into":[79],"number":[82],"metabolites.":[84],"Distribution":[85],"studies":[86],"shown":[88],"that":[89],"therapeutically":[90],"levels":[92,109],"intraconazole":[94],"maintained":[96],"much":[97],"longer":[98],"some":[100],"infected":[101],"tissues":[102],"plasma.":[105],"For":[106],"instance,":[107],"persist":[110],"for":[111,123],"four":[112,124],"days":[113],"vaginal":[116],"epithelium":[117],"after":[118,133],"one-day":[120],"treatment":[121,134],"weeks":[125],"stratum":[128],"corneum":[129],"skin":[132],"has":[135],"been":[136],"stopped.":[137],"These":[138,175,217],"unique":[139],"characteristics":[141],"may":[142,220],"explain":[143],"why":[144],"low":[148],"plasma":[149,182],"(but":[151],"high":[153,224],"concentrations)":[155],"as":[157,159],"effective":[158],"Fluconazole":[161],"interacts":[162],"cytochrome":[164],"P450-dependent":[165],"enzyme":[166],"activities":[167],"hepatic":[169],"microsomes":[170],"rats":[172],"mice.":[174],"effects":[176],"rodents":[178],"seen":[180],"at":[181,194],"liver":[184],"fluconazole":[187],"comparable":[188],"those":[190],"obtained":[191],"therapeutic":[195],"dose":[196],"levels.":[197],"Unlike":[198],"fluconazole,":[199],"does":[201],"not":[202],"interfere":[203],"mammalian":[205],"drug-metabolising":[206],"enzymes,":[207],"minimising":[208],"risk":[210],"interaction":[212],"concomitantly":[214],"administered":[215],"drugs.":[216],"properties":[219],"contribute":[221],"efficacy":[225],"safety":[227],"patients":[231],"various":[233],"mycotic":[234],"infections.":[235]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W38472955","counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
